Swine influenza: Nephrologist's perspective

Iranian Journal of Kidney Diseases

Volumn 3, Issue 3, 2009, Pages 175-176

  Gupta, Ankur ^a   Ignatius, Avinash ^a   Khaira, Ambar ^a   Agarwal, Sanjay Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; STEROID; TACROLIMUS; ZANAMIVIR; ANTIVIRUS AGENT;

AREA UNDER THE CURVE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HAND WASHING; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA VIRUS A H1N1; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LETTER; NONHUMAN; PREVENTIVE MEDICINE; SWINE DISEASE; SWINE INFLUENZA VIRUS; VIRUS STRAIN; VIRUS TRANSMISSION; CHRONIC KIDNEY FAILURE; INFLUENZA; NEPHROLOGY;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEPHROLOGY; OSELTAMIVIR; RENAL INSUFFICIENCY, CHRONIC; ZANAMIVIR;

EID: 70349924057     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Gallaher WR. Towards a sane and rational approach to management of Influenza H1N1 2009. Virol J. 2009;6:51.
2. He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet. 1999;37:471-84.
3. Robson R, Buttimore A, Lynn K, Brewster M, Ward P. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2006;21:2556-62.
4. Cass LM, Efthymiopoulos C, Marsh J, Bye A. Effect of renal impairment on the pharmacokinetics of intravenous zanamivir. Clin Pharmacokinet. 1999;36 Suppl 1:13-9.